These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Considerations in boosting COVID-19 vaccine immune responses. Krause PR; Fleming TR; Peto R; Longini IM; Figueroa JP; Sterne JAC; Cravioto A; Rees H; Higgins JPT; Boutron I; Pan H; Gruber MF; Arora N; Kazi F; Gaspar R; Swaminathan S; Ryan MJ; Henao-Restrepo AM Lancet; 2021 Oct; 398(10308):1377-1380. PubMed ID: 34534516 [No Abstract] [Full Text] [Related]
44. Audio Interview: Waning Immunity against SARS-CoV-2. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2021 Dec; 385(24):e99. PubMed ID: 34879456 [No Abstract] [Full Text] [Related]
45. Scientists see a 'really, really tough winter' with Omicron. Kupferschmidt K Science; 2021 Dec; 374(6574):1421-1422. PubMed ID: 34914506 [No Abstract] [Full Text] [Related]
46. Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2021 Sep; 385(12):e48. PubMed ID: 34525292 [No Abstract] [Full Text] [Related]
47. Circadian Variation in the Response to Vaccination: A Systematic Review and Evidence Appraisal. Wyse CA; Rudderham LM; Nordon EA; Ince LM; Coogan AN; Lopez LM J Biol Rhythms; 2024 Jun; 39(3):219-236. PubMed ID: 38459699 [TBL] [Abstract][Full Text] [Related]
48. Vaccine hesitancy and COVID-19 vaccination in Hong Kong. Chan PKS; Wong MCS; Wong ELY Hong Kong Med J; 2021 Apr; 27(2):90-91. PubMed ID: 33879624 [No Abstract] [Full Text] [Related]
49. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days. Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R Front Immunol; 2021; 12():726960. PubMed ID: 34671348 [TBL] [Abstract][Full Text] [Related]
50. Herd immunization with childhood vaccination may provide protection against COVID-19. Yu Y Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604 [TBL] [Abstract][Full Text] [Related]
54. Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution. Griffiths EA; Segal BH Cancer Cell; 2021 Aug; 39(8):1045-1047. PubMed ID: 34242573 [TBL] [Abstract][Full Text] [Related]
55. Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2021 Mar; 384(11):e53. PubMed ID: 33730461 [No Abstract] [Full Text] [Related]
56. Audio Interview: How Well Are Covid-19 Vaccines Working? Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2021 Jul; 385(2):e15. PubMed ID: 34233102 [No Abstract] [Full Text] [Related]
57. SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines. Khan A; Khan T; Ali S; Aftab S; Wang Y; Qiankun W; Khan M; Suleman M; Ali S; Heng W; Ali SS; Wei DQ; Mohammad A Biomed Pharmacother; 2021 Nov; 143():112176. PubMed ID: 34562770 [TBL] [Abstract][Full Text] [Related]
58. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection. Li M; Guo J; Lu S; Zhou R; Shi H; Shi X; Cheng L; Liang Q; Liu H; Wang P; Wang N; Wang Y; Fu L; Xing M; Wang R; Ju B; Liu L; Lau SY; Jia W; Tong X; Yuan L; Guo Y; Qi H; Zhang Q; Huang Z; Chen H; Zhang Z; Chen Z; Peng X; Zhou D; Zhang L Front Immunol; 2021; 12():697074. PubMed ID: 34262569 [TBL] [Abstract][Full Text] [Related]